FindTrial
Sign In

Effect of Kt/V on mortality among patients with ESRD undergoing twice-weekly hemodialysis.

Effect of Kt/V on mortality among patients with ESRD undergoing twice-weekly hemodialysis.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20130518001
Enrollment
Unknown
Registered
2013-05-18
Start date
2011-02-02
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

There is limited data about effect of Kt/v on mortality among ESRD patients undergoing twice&#45

Interventions

Prevention

Sponsors

Royal College of Physician Thailand
Lead Sponsor
The Medical Association of Thailand
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ESRD patients who were treated with twice-weekly or trice-weekly hemodialysis for at least 3 month.

Exclusion criteria

Exclusion criteria: 1.Impaired mental function that can not understand the protocol. 3.Who had severe congestive heart failure, bed-ridden status or advance malignancy.

Design outcomes

Primary

MeasureTime frame
Disease related mortality 12 month observation—

Secondary

MeasureTime frame
Hospitalization 12 month observation—

Contacts

Public ContactWerapan Supanchaimat

Khon Kaen Hospital

werapan@moph.go.th66-4333-6789

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026